Correlation Between Vericel Corp and SpringWorks Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vericel Corp and SpringWorks Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vericel Corp and SpringWorks Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vericel Corp Ord and SpringWorks Therapeutics, you can compare the effects of market volatilities on Vericel Corp and SpringWorks Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vericel Corp with a short position of SpringWorks Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vericel Corp and SpringWorks Therapeutics.

Diversification Opportunities for Vericel Corp and SpringWorks Therapeutics

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Vericel and SpringWorks is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Vericel Corp Ord and SpringWorks Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SpringWorks Therapeutics and Vericel Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vericel Corp Ord are associated (or correlated) with SpringWorks Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SpringWorks Therapeutics has no effect on the direction of Vericel Corp i.e., Vericel Corp and SpringWorks Therapeutics go up and down completely randomly.

Pair Corralation between Vericel Corp and SpringWorks Therapeutics

Given the investment horizon of 90 days Vericel Corp Ord is expected to generate 16.57 times more return on investment than SpringWorks Therapeutics. However, Vericel Corp is 16.57 times more volatile than SpringWorks Therapeutics. It trades about 0.04 of its potential returns per unit of risk. SpringWorks Therapeutics is currently generating about 0.22 per unit of risk. If you would invest  3,936  in Vericel Corp Ord on April 29, 2025 and sell it today you would earn a total of  209.00  from holding Vericel Corp Ord or generate 5.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy70.97%
ValuesDaily Returns

Vericel Corp Ord  vs.  SpringWorks Therapeutics

 Performance 
       Timeline  
Vericel Corp Ord 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Vericel Corp Ord are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady technical and fundamental indicators, Vericel Corp may actually be approaching a critical reversion point that can send shares even higher in August 2025.
SpringWorks Therapeutics 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Over the last 90 days SpringWorks Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, SpringWorks Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Vericel Corp and SpringWorks Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vericel Corp and SpringWorks Therapeutics

The main advantage of trading using opposite Vericel Corp and SpringWorks Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vericel Corp position performs unexpectedly, SpringWorks Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SpringWorks Therapeutics will offset losses from the drop in SpringWorks Therapeutics' long position.
The idea behind Vericel Corp Ord and SpringWorks Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges